About 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine
1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine (PubChem CID 161046981) has the molecular formula C28H32F2N8O4
and a molecular weight of 582.61 g/mol. Its IUPAC name is 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine.
Molecular Properties
| Compound Name | 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine |
| PubChem CID | 161046981 |
| Molecular Formula | C28H32F2N8O4 |
| Molecular Weight | 582.61 g/mol |
| Exact Mass | 582.25 |
| IUPAC Name | 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine |
| SMILES | CCOC1CC(n2cc(N)c(-c3ncccc3F)n2)C1.CCOC1CC(n2cc([N+](=O)[O-])c(-c3ncccc3F)n2)C1 |
| InChI | InChI=1S/C14H15FN4O3.C14H17FN4O/c1-2-22-10-6-9(7-10)18-8-12(19(20)21)14(17-18)13-11(15)4-3-5-16-13;1-2-20-10-6-9(7-10)19-8-12(16)14(18-19)13-11(15)4-3-5-17-13/h3-5,8-10H,2,6-7H2,1H3;3-5,8-10H,2,6-7,16H2,1H3 |
| InChIKey | UBPXQQMSAMGIQN-UHFFFAOYSA-N |
| XLogP | 5.14 |
| TPSA | 149.04 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
| MW ≤ 500 | 582.61 |
| LogP ≤ 5 | 5.14 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine?
The IUPAC name of 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine (CID 161046981) is 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine.
What is the SMILES notation for 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine?
The canonical SMILES for 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine is CCOC1CC(n2cc(N)c(-c3ncccc3F)n2)C1.CCOC1CC(n2cc([N+](=O)[O-])c(-c3ncccc3F)n2)C1.
What is the InChIKey of 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine?
The InChIKey is UBPXQQMSAMGIQN-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H15FN4O3.C14H17FN4O/c1-2-22-10-6-9(7-10)18-8-12(19(20)21)14(17-18)13-11(15)4-3-5-16-13;1-2-20-10-6-9(7-10)19-8-12(16)14(18-19)13-11(15)4-3-5-17-13/h3-5,8-10H,2,6-7H2,1H3;3-5,8-10H,2,6-7,16H2,1H3.
What are the key properties of 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine?
1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine has a molecular weight of 582.61 g/mol, XLogP of 5.14, 9 rotatable bonds, 1 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(3-ethoxycyclobutyl)-3-(3-fluoro-2-pyridinyl)pyrazol-4-amine;2-[1-(3-ethoxycyclobutyl)-4-nitropyrazol-3-yl]-3-fluoropyridine is sourced from PubChem (CID 161046981), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).